Literature DB >> 10384683

Causes and prevalence of non-vision impairing ocular conditions among a rural adult population in sw Uganda.

A Kamali1, J A Whitworth, A Ruberantwari, F Mulwanyi, M Acakara, P Dolin, G Johnson.   

Abstract

Information is scanty about the extent of ocular morbidity in developing countries, particularly for non-vision impairing conditions (NVIC), although these constitute the majority of consultations in eye clinics. We have conducted a survey to determine the prevalence and causes of NVIC in a Ugandan adult population and compared our findings with the work pattern of the district hospital. Adults were screened using Snellen's illiterate E chart and those found with visual impairment (acuity less than 6/18) in either eye were referred to a low-vision clinic, and those with obvious ocular disease or symptoms, but without visual impairment, to an outreach clinic. A total of 2886 (53%) out of 5479 adults were screened. Of these, 257 (8.9%) were referred to the outreach clinic, of whom 173 (67%) attended. Of those attending the low-vision clinic 83% had visual impairment confirmed, and 92% of those attending the outreach clinic were confirmed not to have visual impairment. The four commonest NVIC observed at the outreach clinic were: presbyopia (48%), allergic conjunctivitis (20%), early cataract (9%) and infective conjunctivitis (8%), the same conditions as those most commonly seen at the district hospital. In this community, over 80% of NVIC are caused by four conditions which are potentially either correctable, operable or treatable. Training health workers to recognise and treat these conditions would serve the great majority of eye patients. Hospital activity data can be used cautiously to assess the relative frequency of NVIC in the community.

Entities:  

Mesh:

Year:  1999        PMID: 10384683     DOI: 10.1076/opep.6.1.41.1572

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  8 in total

Review 1.  Blindness in Africa: present situation and future needs.

Authors:  S Lewallen; P Courtright
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

2.  Presbyopia: prevalence, impact, and interventions.

Authors:  Ilesh Patel; Sheila K West
Journal:  Community Eye Health       Date:  2007-09

3.  Presbyopia among public senior high school teachers in the Kumasi metropolis.

Authors:  D B Kumah; S Y Lartey; K Amoah-Duah
Journal:  Ghana Med J       Date:  2011-03

4.  PREVALENCE AND PATTERN OF PRESBYOPIA IN A RURAL NIGERIAN COMMUNITY.

Authors:  T S Obajolowo; Jfa Owoeye; F G Adepoju
Journal:  J West Afr Coll Surg       Date:  2016 Jul-Sep

5.  Incidence of visual loss in rural southwest Uganda.

Authors:  S M Mbulaiteye; B C Reeves; F Mulwanyi; J A G Whitworth; G Johnson
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

6.  The general population cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies.

Authors:  Gershim Asiki; Georgina Murphy; Jessica Nakiyingi-Miiro; Janet Seeley; Rebecca N Nsubuga; Alex Karabarinde; Laban Waswa; Sam Biraro; Ivan Kasamba; Cristina Pomilla; Dermot Maher; Elizabeth H Young; Anatoli Kamali; Manjinder S Sandhu
Journal:  Int J Epidemiol       Date:  2013-01-30       Impact factor: 7.196

7.  Prevalence of ocular findings regardless of visual acuity status in older adults from the Brazilian Amazon Region.

Authors:  Arthur G Fernandes; Adriana Berezovsky; Sung E S Watanabe; Márcia R K H Mitsuhiro; Marcela C Cypel; Nívea N Ferraz; João M Furtado; Paula Y Sacai; Sergio Muñoz; Cristina C Cunha; Galton C Vasconcelos; Paulo H A Morales; Marcos J Cohen; Jacob M Cohen; Mauro Campos; Rubens Belfort; Solange R Salomão
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

8.  Prevalence and causes of ocular morbidity in Mbeere District, Kenya. Results of a population-based survey.

Authors:  Kahaki Kimani; Robert Lindfield; Laura Senyonjo; Alex Mwaniki; Elena Schmidt
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.